Surmodics reported $-5651000 in Net Income for its second fiscal quarter of 2022.

Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
Net Income Change
Abbott ABT:US $ 2018M 429M
Align Technology ALGN:US $ 112.8M 21.5M
Anika Therapeutics ANIK:US $ -2.84M 0.09M
Arrowhead Research ARWR:US $ -72046000 116.41M
Baxter International BAX:US $ 252M 181M
Bioscrip BIOS:US $ 33.93M 3.65M
Boston Scientific BSX:US $ 260M 149M
Cryolife CRY:US $ -4.26M 0.87M
Edap Tms EDAP:US $ 1.92M 1.52M
Edwards Lifesciences EW:US $ 406.4M 32.8M
Haemonetics HAE:US $ 19.88M 10.14M
Johnson & Johnson JNJ:US $ 4814M 335M
Merit Medical Systems MMSI:US $ 15.3M 4.75M
Mesa Laboratories MLAB:US $ -1.44M 0.35M
Nektar Therapeutics NKTR:US $ -159.07M 68.68M
Stryker SYK:US $ 656M 333M
Surmodics SRDX:US $ -5.65M 1.57M
Trinity Biotech TRIB:US $ -12.28M 11.01M